Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1248/YAKUSHI.123.369PMID 12772594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR.

  2002cited by this paper
• Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity.

  2001cited by this paper
• Induction of CYP2C genes in human hepatocytes in primary culture.

  2001cited by this paper
• Use of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver.

  2000cited by this paper
• Quantitative RT-PCR measurement of human cytochrome P-450s: application to drug induction studies.

  2000cited by this paper
• Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.

  2000cited by this paper
• Fetal hepatic drug elimination.

  1999cited by this paper
• Cytochrome P450 3A

  1999cited by this paper
• Characterization of human small intestinal cytochromes P-450.

  1999cited by this paper
• Quantitation of cytochrome P450 mRNAs in patients with suspected liver diseases as assessed by reverse transcriptase-polymerase chain reaction.

  1999cited by this paper
• One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses

  1999cited by this paper
• Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver.

  1999cited by this paper
• Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue.

  1999cited by this paper
• Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.

  1998cited by this paper
• Quantification of Multiple Human Cytochrome P450 mRNA Molecules Using Competitive Reverse Transcriptase-PCR

  1998cited by this paper
• Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

  1997cited by this paper
• Quantitative reverse transcriptase/PCR assay for the measurement of induction in cultured hepatocytes.

  1997cited by this paper
• Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta.

  1996cited by this paper
• Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver.

  1994cited by this paper
• Human cytochromes P450: problems and prospects.

  1992cited by this paper
• Molecular genetics of the P-450 superfamily.

  1990cited by this paper

• Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder

  2025cites this paper
• Association of Age-Related Macular Degeneration with Cholelithiasis

  2025cites this paper
• Advanced in vitro evaluation of drug-induced kidney injury using microphysiological systems in drug discovery and development.

  2025cites this paper
• Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation

  2025cites this paper
• Evaluation of stabilizing additives to protect activities of cytochrome P450 enzymes for in vitro drug testing and pharmacogenetic studies: Focus on CYP2D6.

  2025cites this paper
• PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine

  2024cites this paper
• Investigation of Functional Cytochrome P450 4A Enzymes in Liver and Kidney of Pigs, Cats, Tree Shrews, and Dogs in Comparison with the Metabolic Capacity of Human P450 4A11

  2024cites this paper
• Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

  2024cites this paper
• Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions

  2024cites this paper
• Apiole, an important constituent of parsley, is a mixed-type inhibitor of the CYP1A subfamily.

  2024cites this paper
• Refined diet consumption increases neuroinflammatory signalling through bile acid dysmetabolism

  2024cites this paper
• Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications

  2024cites this paper
• Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights

  2024cites this paper
• Risk characterization of N-nitrosodimethylamine in pharmaceuticals.

  2024cites this paper
• PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?

  2024cites this paper
• Regulatory mechanisms and pathological implications of CYP24A1 in Vitamin D metabolism.

  2024cites this paper
• Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis.

  2024cites this paper
• Physiologically based pharmacokinetic modeling of tacrolimus for food–drug and CYP3A drug–drug–gene interaction predictions

  2023influential citation
• Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib.

  2023cites this paper
• Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure

  2023cites this paper
• Effects of maternal exposure to procymidone on hepatic metabolism in the offspring of mice

  2023cites this paper
• Applied physiologically‐based pharmacokinetic modeling to assess uridine diphosphate‐glucuronosyltransferase‐mediated drug–drug interactions for Vericiguat

  2023influential citation
• A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.

  2023cites this paper
• Quantitative Translation of Substrate Intrinsic Clearance from Recombinant CYP1A1 to Humans

  2023cites this paper
• Construction of a fused grid-based CYP2C18-Template system and its application to drug metabolism.

  2023cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism

  2022cites this paper
• Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling

  2022cites this paper
• Bile acids and neurological disease.

  2022cites this paper
• The octadecanoids: an emerging class of lipid mediators

  2022cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes

  2022cites this paper
• Predicting Human Fetal Drug Exposure Through Maternal‐Fetal PBPK Modeling and In Vitro or Ex Vivo Studies

  2022cites this paper
• Polymorphic cytochromes P450 in non-human primates.

  2022cites this paper
• Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions

  2022cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes

  2022cites this paper
• Bergamottin a CYP3A inhibitor found in grapefruit juice inhibits prostate cancer cell growth by downregulating androgen receptor signaling and promoting G0/G1 cell cycle block and apoptosis

  2021cites this paper
• Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction

  2021cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism

  2021cites this paper
• Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

  2021cites this paper
• Does the food processing contaminant acrylamide cause developmental neurotoxicity? A review and identification of knowledge gaps.

  2021cites this paper
• The Placenta as a Target for Alcohol During Pregnancy: The Close Relation with IGFs Signaling Pathway.

  2021cites this paper
• Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.

  2021cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes

  2021cites this paper
• Structure-based virtual screening of CYP1A1 inhibitors: towards rapid tier-one assessment of potential developmental toxicants

  2021cites this paper
• Adrenal Androgens, Adrenarche, and Zona Reticularis: a human affair?

  2021cites this paper
• Transplacental transfer of venlafaxine evaluated by ex vivo perfusion.

  2021cites this paper
• Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus

  2020cites this paper
• Alteration of CYP4A11 expression in renal cell carcinoma: diagnostic and prognostic implications

  2020cites this paper
• Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer

  2020cites this paper
• The role of xenobiotic-metabolizing enzymes in the placenta: a growing research field

  2020cites this paper
• Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

  2020cites this paper
• The Biosynthesis of Enzymatically Oxidized Lipids

  2020cites this paper
• Bile Acids: A Communication Channel in the Gut-Brain Axis

  2020cites this paper
• Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients

  2020cites this paper
• Хронічні аномальні маткові кровотечі та якість життя жінки. Як суттєво покращити результат

  2020cites this paper
• Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug‐Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

  2020cites this paper
• Hepatic transcriptional profile and tissue distribution of cytochrome P450 1-3 genes in the red-crowned crane Grus japonensis.

  2020cites this paper
• Altered hepatic cytochrome P450 expression in cats after chronic exposure to decabromodiphenyl ether (BDE-209)

  2020cites this paper
• Role of Cytochrome P450 in Prostate Cancer and its Therapy

  2020cites this paper
• Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

  2020cites this paper
• Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel

  2020cites this paper
• Pharmacokinetics and Pharmacodynamics

  2020cites this paper
• CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design.

  2020cites this paper
• Plasma Concentration of Tamoxifen and Its Metabolites in a Neonate and Mother Receiving Tamoxifen: A Case Report of a Pregnant Woman.

  2019cites this paper
• Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene

  2019influential citation
• Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver

  2019cites this paper
• Ligand-Based Pharmacophore Modeling and Virtual Screening to discover novel CYP1A1 Inhibitors.

  2019cites this paper
• The label-free detection and distinction of CYP2C9-expressing and non-expressing cells by surface-enhanced Raman scattering substrates based on bimetallic AuNPs–AgNWs

  2019cites this paper
• Dietary lipids and environmental xenobiotics as risk factors for prostate cancer: The role of cytochrome P450

  2019cites this paper
• Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD)

  2019cites this paper
• Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism

  2019cites this paper
• Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients

  2019cites this paper
• Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans.

  2019cites this paper
• Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers

  2019cites this paper
• Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization

  2019cites this paper
• Étude du profil d’expression des cytochromes P450 dans le carcinome hépatocellulaire : à la recherche de nouveaux biomarqueurs

  2019cites this paper
• Cloning and tissue expression of cytochrome P450 2S1, 4V2, 7A1, 7B1, 8B1, 24A1, 26A1, 26C1, 27A1, 39A1, and 51A1 in marmosets.

  2019cites this paper
• The marmoset cytochrome P450 superfamily: sequence/phylogenetic analyses, genomic structure, and catalytic function.

  2019cites this paper
• Introduction to Human Cytochrome P450 Superfamily

  2018cites this paper
• The Placental Barrier: the Gate and the Fate in Drug Distribution

  2018cites this paper
• Marmoset pulmonary cytochrome P450 2F1 oxidizes biphenyl and 7-ethoxycoumarin and hepatic human P450 substrates

  2018cites this paper
• HIGH-THROUGHPUT METABOLISM-INDUCED TOXICITY ASSAYS ON A 384-PILLAR PLATE

  2018cites this paper
• High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.

  2018cites this paper
• Substrates of Human CYP2D6

  2018cites this paper
• Mechanisms and the clinical relevance of complex drug–drug interactions

  2018cites this paper
• Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment

  2018cites this paper
• 15.12 – Selected Pneumotoxic Agents☆

  2018cites this paper
• Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans

  2018cites this paper
• Expression of clinically relevant drug‐metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra‐subject analysis

  2018cites this paper
• Myeloperoxidase-Mediated Bioactivation of Olefins

  2018cites this paper
• Cytochrome P450 4A11 expression in tumor cells: A favorable prognostic factor for hepatocellular carcinoma patients

  2018cites this paper
• PBPK Models for CYP3A4 and P‐gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin

  2018cites this paper
• Measurement of the inhibition of cytochrome P450 enzymes by pyrethroid pesticides

  2018cites this paper
• Interactions between Over-the-Counter and Illicit Drugs Utilizing Cytochrome P450 Metabolism: Potential for Exacerbation of Pharmacological Response

  2017cites this paper
• Characterization of feline cytochrome P450 2B6

  2017cites this paper
• Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer

  2017cites this paper
• 22 – Drug Distribution in Fetal Life

  2017cites this paper
• Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study

  2017cites this paper
• Functional characterization and tissue expression of marmoset cytochrome P450 2E1

  2017cites this paper
• Instructions for use Title Metabolic Activation of Heterocyclic Amines and Expression of CYP 1 A 1 in the Tongue Author ( s )

  2017cites this paper
• Marmoset cytochrome P450 4A11, a novel arachidonic acid and lauric acid ω-hydroxylase expressed in liver and kidney tissues

  2017cites this paper